Postpartum thyroiditis future or investigational therapies: Difference between revisions

	Postpartum thyroiditis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Postpartum Thyroiditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Postpartum thyroiditis future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Postpartum thyroiditis future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Postpartum thyroiditis future or investigational therapies
CDC on Postpartum thyroiditis future or investigational therapies
Postpartum thyroiditis future or investigational therapies in the news
Blogs on Postpartum thyroiditis future or investigational therapies
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Postpartum thyroiditis future or investigational therapies

Latest revision as of 17:55, 15 November 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Postpartum thyroiditis}}
-{{CMG}}; {{AE}}
+{{CMG}}; {{AE}}{{SKA}}
 ==Overview==
-Postpartum thyroiditis is under research for establishing exact parthenogenesis and treatment.
 ==Future or Investigational Therapies==
-Postpartum thyroiditis is under research for establishing exact parthenogenesis and treatment.
-Clinical trails for establishing treatment of PPT is under way. However anti-TPO high titers have been associated with chances of PPT occurrence but it is not always the case so the mechanism of autoimmune system causing transient destruction of thyroid follicles during postpartum is largely under debate.
-Thyroid hormone plays important role in development of fetus and its malfunction leads to significant female morbidity so preventive measure as use of selenium and adequate iodine uptake are under trails to establish significant role on large scale.
-Microscopic picture of late phase of PPT are similar to silent thyroiditis however there is limited data on early microscopic picture of PPT which is different than other autoimmune disease of thyroid gland
-There is limited amount of literature on novel gene for CD60 CD4 T cell mutation which play role in PPT etiopathogensis and it is under research to gather more case studies.
 ==References==